Business
Acadia Healthcare Reports Third Quarter 2025 Results
Third Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year Lowering Full-Year Outlook Acadia Taking Decisive Actions to Optimize Portfolio in
About this update from Acadia Healthcare Company, Inc.
[{"type":"text","content":"\nThird Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year\n\nLowering Full-Year Outlook\n\nAcadia Taking Decisive Actions to Optimize Portfolio in Order to Reduce Capital Expenditures and Increase Free Cash Flow Generation\n\nReferral Initiatives Drive Accelerating Admissions Growth\n\nTodd Young joined as CFO on October 27; Announces departure of COO Dr. Nasser Khan\n\n FRANKLIN, Tenn.--(BUSINESS WIRE)--\nAcadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2025.\n\nThird Quarter 2025 Results\n\n\nRevenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024\n\n\nSame facility revenue increased 3.7% compared with the third quarter of 2024, including an increase in revenue per patient day of 2.3% and an increase in patient days of 1.3%\n\n\nSame facility admissions grew 3.3% compared to the third quarter of 2024\n\n\nNet income attributable to Acadia totaled $36.2 million, or $0.40 per diluted share, vs $0.74 per diluted share in the prior-year period\n\n\nAdjusted income attributable to Acadia totaled $64.8 million, or $0.72 per diluted share, vs $0.91 per diluted share in the prior-year period\n\n\nAdjusted EBITDA was $173.0 million, compared with $194.3 million in the prior-year period\n\n\nAdded 83 newly licensed beds to existing facilities and 346 beds to new facilities in the third quarter\n\n\nFull Year Financial Guidance\n\n\nLowering revenue guidance to $3.28 billion to $3.30 billion from the prior range of $3.30 billion to $3.35 billion\n\n\nLowering Adjusted EBITDA guidance to $650 million to $660 million from the prior range of $675 million to $700 million\n\n\nLowering Adjusted earnings per share guidance to $2.35 to $2.45 from the prior range of $2.45 to $2.65\n\n\nSee table below for a full summary of revised guidance\n\n\nRevenue Performance by Service Type\n\n\nAcute inpatient psychiatric facilities: Revenue totaled $471.5 million, an increase of 7.2% over the third quarter of 2024\n\n\nSpecialty treatment facilities: Revenue totaled $148.1 million, a decrease of 4.9% over the third quarter of 2024, reflecting certain facilities closed over the last twelve months\n\n\nComprehensive treatment centers: Revenue totaled $144.5 million, an increase of 7.7% over the third quarter of 2024...